CoChat

Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine: Implications for Disease Prevention in the United States

The DOI matches its Crossref record; 49 of the 51 references it cites were found in a registry or an index.

Abstract

BACKGROUND: During the decade 1998-2007, a combination DTaP(5)-IPV/Hib vaccine was used exclusively in Canada to immunize infants and young children against diphtheria, tetanus, pertussis, polio, and invasive Haemophilus influenzae type b (Hib) disease. METHODS: Medline was used to search for publications during 1996-2008 related to the epidemiology and vaccine prevention of pertussis and invasive Hib disease in Canada. Related abstracts and presentations were reviewed, when available, and epidemiologic data since 1985 were obtained from the Public Health Agency of Canada public Web site. RESULTS: Reports of pertussis have declined substantially in preschool and school-aged children during the past decade, and cyclical peaks in disease incidence have been blunted or eliminated. In provinces and territories where Tdap(5) vaccine has been administered to 14- to 16-year-olds, marked reductions of pertussis have been documented in adolescents as well as younger age groups, possibly due to herd immunity. Incidence rates of invasive Hib disease among Canadian children <5 years declined markedly after introduction of Hib conjugate vaccines, and the disease has remained under control with exclusive use of DTaP(5)-IPV/Hib vaccine. Most cases of invasive Hib disease occur among unimmunized or only partially vaccinated children. The reduction of Hib case reports has been documented throughout Canada, including among Aboriginal children who are at high risk for this disease. CONCLUSIONS: The Canadian experience with DTaP(5)-IPV/Hib and Tdap(5) vaccines is relevant to the United States because immunization schedules, vaccination coverage rates, and epidemiologic patterns of pertussis and Hib diseases are similar in the 2 countries, and because both vaccines are licensed for use in the United States.

Overview

Integrity signals

Registry

Crossref · 10.1097/inf.0b013e318199d2fc

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Research works printed but not linked: 4

  1. 2000, Health Canada. Case definitions for diseases under national surveillance., Can Commun Dis Rep, 26, 101
  2. Scheifele, 1996, Recent trends in pediatric Haemophilus influenzae type b infections in Canada., Can Med Assoc J, 154, 1041
  3. 2005, IMPACT highlights. Invasive Haemophilus influenzae type b cases–2004., Paediatr Child Health, 10, 314
  4. Bettinger, 2005, Epidemiology of hospitalized pertussis after change from whole-cell to acellular pertussis vaccine. 6th Canadian Immunization Conference 2004., CCDR, 31

Cited by

See all 40

Metadata

Authors
Greenberg, D. P., Doemland, M., Bettinger, J. A., Scheifele, D. W., Halperin, S. A., Waters, V., & Kandola, K.
Affiliations
  • Sanofi (United States) (US)
  • University of British Columbia (CA)
  • Dalhousie University (CA)
  • Hospital for Sick Children (CA)
  • Government of Northwest Territories (CA)
Corresponding author
  • Greenberg, David P.
  • Doemland, Martha
Venue
Pediatric Infectious Disease Journal
Published
2009-06
Volume
28
Issue
6
Pages
521-528
ISSN
0891-3668 (ISSN-L)
OpenAlex
W2100431291
Cited by
40
References
51
Citations by year
2023: 1 · 2020: 4 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 6
FWCI
4.79
Type
journal article
Language
en
Open access
closed
Locations
  • The Pediatric Infectious Disease Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Health Sciences › Medicine › Infectious Diseases › Diphtheria, Corynebacterium, and Tetanus
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords
pertussis, Haemophilus influenzae type b, invasive Hib disease, DTaP-IPV-Hib vaccine, Tdap vaccine, acellular pertussis vaccine, vaccine epidemiology, herd immunity, vaccination coverage, Aboriginal children, Canada, United States
MeSH terms
Adolescent, Adult, Canada, Child, Child, Preschool, Inuit, Haemophilus Infections, Humans, Infant, Poliovirus Vaccine, Inactivated, Population Surveillance, United States, Whooping Cough, Diphtheria-Tetanus-Pertussis Vaccine, Vaccines, Combined, Haemophilus Vaccines, Vaccines, Conjugate, Haemophilus influenzae type b, Diphtheria-Tetanus-acellular Pertussis Vaccines, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine: Implications for Disease Prevention in the United States. https://app.cochat.ai/papers/10.1097/inf.0b013e318199d2fc
The paper
Greenberg, D. P., Doemland, M., Bettinger, J. A., Scheifele, D. W., Halperin, S. A., Waters, V., & Kandola, K. (2009). Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine: Implications for Disease Prevention in the United States. Pediatric Infectious Disease Journal. https://doi.org/10.1097/inf.0b013e318199d2fc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.